Does off-pump coronary bypass provide reduced mortality and morbidity and equivalent 10-year survival?
OPCAB provides significant early mortality and morbidity advantages, especially for women. During the 10-year follow-up, OPCAB and CPB result in similar survival, regardless of gender.
Our results suggest that ADAMTS1 is a novel susceptibility gene for KBD.